Steve Pet

Steve Pet is an associate in the Washington, DC office of Gibson, Dunn & Crutcher and a member of the firm’s Antitrust and Competition Practice Group.

He advises clients on all aspects of antitrust law, with a focus on merger and conduct investigations before the Federal Trade Commission, the Department of Justice, and state attorneys general. Steve also represents clients in complex private and government antitrust litigation, and has significant experience litigating and counseling on Robinson-Patman Act matters. His experience spans a broad range of industries, including healthcare, pharmaceuticals, consumer products, energy, satellite communications, and technology.

An active leader in the antitrust bar, Steve serves as Vice Chair of the ABA Antitrust Section’s Mergers and Acquisitions Committee and has previously served as Vice Chair of the Agriculture and Food Committee and the U.S. Comments & Policy Committee. Before law school, he spent three years as an Honors Paralegal in the FTC’s Bureau of Competition, working at both the staff level and in the Bureau Director’s Office on major enforcement matters, including the FTC’s successful challenge to the proposed $3.5 billion Sysco–U.S. Foods merger.

Steve received his law degree from the University of Virginia School of Law, where he graduated Order of the Coif and served on the Virginia Law Review. Steve earned a Bachelor of Arts degree summa cum laude from Hamilton College.

Representative matters include*

Merger Reviews and Government Antitrust Investigations

• Represented Amazon in securing the FTC’s unconditional clearance of Amazon’s acquisition of One Medical
• Represented Pioneer Natural Resources in securing the FTC’s clearance of ExxonMobil’s $64.5 billion acquisition of Pioneer, which created the largest oil and gas producer in the Permian Basin
• Represented SES in securing unconditional clearance from DOJ and numerous other competition authorities of SES’s acquisition of Intelsat, a global satellite competitor
• Represented Celgene in securing the FTC’s conditional approval of its $74 billion acquisition by Bristol-Myers Squibb
• Represented Arch Resources in securing unconditional approval of its $5 billion dollar merger with Consol Energy to form Core Natural Resources
• Represented DaVita in securing the FTC’s conditional approval of its acquisition of the University of Utah’s dialysis business
• Represented Merck in securing global antitrust clearance for its acquisition of Prometheus Biosciences
• Represented General Electric in its acquisition of BK Medical
• Represented Zensho Holdings in its acquisition of Snowfox Group
• Represented large technology company in FTC 6(b) study on non-reportable acquisitions, and global food producer in FTC 6(b) study on supply chain disruptions 

Antitrust Litigation

• Represented PepsiCo in Robinson-Patman litigation brought by the FTC; the FTC voluntarily dismissed the case without conditions (S.D.N.Y.)
• Representing Frito-Lay in putative class action alleging Robinson-Patman and state law claims (C.D. Cal.)
• Representing Boehringer Ingelheim in antitrust class actions involving alleged monopolization based on FDA Orange-Book listings (D. Mass.)
• Represented Arch Coal in its proposed joint venture with Peabody Energy, from initial investigation through Section Request and litigation against the FTC (E.D. Mo.)
• Represented a generic pharmaceutical manufacturer in massive multi-district antitrust litigation brought by state attorneys general and putative private plaintiff classes (E.D. Pa.)

*Includes matters handled prior to joining Gibson Dunn

Steve is admitted to practice in the District of Columbia.

Capabilities

• Antitrust and Competition

Credentials

Education:

• University of Virginia - 2018 Juris Doctor
• Hamilton College - 2012 Bachelor of Arts

Admissions:

• District of Columbia Bar